Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Florida State researchers prepare new antitumor paclitaxel derivatives

March 31, 2003

NIH licensing opportunity: materials and methods for inhibiting Wip1

March 28, 2003

Resubmitted Plenaxis NDA accepted for review

March 28, 2003

Development of BresaGen's E21R takes new direction

March 28, 2003

AEterna signs Neovastat marketing agreement for Korea

March 28, 2003

Novel phthalazine-based protein kinase inhibitors in Pharmacia pipeline

March 28, 2003

New series of PDE10A inhibitors with utility in cancer identified at Bayer

March 28, 2003

Antitumor polyketides prepared and tested at Novartis

March 28, 2003

Novartis patents new antitumor tyrosine kinase inhibitors

March 28, 2003

Progress on three fronts in OGS/Medarex alliance

March 27, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...